Arun J. Sanyal

😲 😲 @ArunJSanyalVCU helped to inaugurate the new Liver and Kidney Transplant Operation Theater Complex and an advanced ICU block of VGM Hospital, Coimbatore, India. bit.ly/455m4Qv #livertwitter #MASH #LT

🤖🧠 An AI model accurately predicted inpatient death on day 1 of admission in patients with #cirrhosis. Developed by @JasmohanBajaj and colleagues @VCU, and published in @AGA_Gastro — it may help guide timely, individualized decisions. #LiverHealth bit.ly/3H3elu1

If you're looking for a world-renowned GI fellowship program, listen/watch @ArunJSanyalVCU discuss the VCU program: No. 9 worldwide, No. 4 in the U.S. and No. 1 in the South. See what we're about. bit.ly/4lWbZfh

Definitions of #liver failure vary➡️tower of Babel in #ACLF Enter @CLEARED_liver with 🌎 input (>120 sites) @AGA_CGH 🔑 liver failure=bili >7.5, INR>1.5 & grade2 #HE ➡️ death 🔑 validated in @MayoClinicGIHep pubmed.ncbi.nlm.nih.gov/40618943/ Informed pubmed.ncbi.nlm.nih.gov/40499736/ @AGA_Gastro

Thank you, @RadcliffeCVRM, for sharing.

I am very grateful for our team, who work so hard to make our patients' lives better.

Very proud of our fellows!

ICYMI: I was honored to participate in @EASLedu's recent online presentation, Steatotic Liver Disease Unpacked: Targeting Dynamic Risks. Watch here. #livertwitter @AleksanderKrag @MeenaBBansal #EASLStudio #LiverXhttps://bit.ly/3FWSvI3

Honored to host @marurinella

📣Today is Global #fattyliverday! We join @globalliver to raise awareness about #fattyliverdisease in [insert country]. Join us and all our partners around the world as we raise awareness about this serious #liverdisease that is on the rise.

🔴 We are now live with @AleksanderKrag, @MeenaBBansal, Mattias Ekstedt and @ArunJSanyalVCU to discuss state-of-the-art diagnostic approaches in #SLD. 👉🏽 Watch here: easl.eu/easl-studio-ep… @EASLnews

Resmetirom was approved for MASH 14 months ago in the US and is likely to gain approval in the EU shortly, with semaglutide close behind. 🩺 Experts are discussing how these approvals changed their clinical practice, and how the first approval opens the gates and clarifies the…

Looking forward to meeting new colleagues in India and discussing the latest in MASLD research.

Looking forward to this!

A great day for liver researchers at VCU. We want to make lives better, not just here, but around the world. Thanks to those who made this day happen -- @saulkarpen and others -- and to the participants for really being keyed into the presentations and activities.

Thrilled to announce the release of the new @ADA_DiabetesPro Consensus Statement: #MASLD is now recognized as a major metabolic complication in type 2 diabetes and obesity, underscoring the central role of insulin resistance and cardiometabolic risk factors in its pathogenesis.…

In @HepCommJournal journals.lww.com/hepcomm/fullte…

Appreciate my colleague @JasmohanBajaj's expertise on this topic as we seek to improve treatment for liver patients with HR.

🎉 Congratulations to Dr. Saul Karpen on receiving the Research Mentor Award, presented by Drs. Don Rockey and Ashwani Singal on behalf of the Liver and Biliary Section of the #AGA at #DDW2025! 🏆 #AASLD #LiverResearch #Hepatology #ResearchExcellence #MentorAward

Looking forward to the conference...